Two Sigma Advisers
SPHS

Two Sigma Advisers’s Sophiris Bio, Inc. SPHS Stock Holding History

Two Sigma Advisers’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,395
Closed -$22K – 2250
2015
Q4 		$22K Buy
+12,395
New +$18.3K ﹤0.01% 1843

Other funds holding SPHS

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Advisers's SPHS Position: Q1 2016 in Review

Two Sigma Advisers sold out of Sophiris Bio, Inc. (SPHS) in Q1 2016, closing a stake of 12,395 shares — an estimated $22K sold.

Two Sigma Advisers first reported a position in SPHS in Q4 2015 and held it in 1 quarter. The position peaked at $22K in Q4 2015. 23 funds tracked by Wall St. Rank hold SPHS as of Q1 2016.

  • Two Sigma Advisers reported no remaining Sophiris Bio, Inc. position as of Q1 2016 after selling out during the quarter.
  • Two Sigma Advisers sold 12,395 Sophiris Bio, Inc. shares in Q1 2016, an estimated $22K.
  • Two Sigma Advisers first reported a position in Sophiris Bio, Inc. in Q4 2015 and held it in 1 quarter.
  • Two Sigma Advisers's Sophiris Bio, Inc. position peaked at $22K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2016.

Based on Two Sigma Advisers's 13F filing for Q1 2016, filed 16 May 2016.